CNVVF Stock: ConvaTec Group Plc Stock Price, Analysis & Insights
Get live CNVVF stock price $2.67, comprehensive ConvaTec Group Plc stock analysis, charts, news, and expert forecast. Real-time CNVVF stock data and investment insights.
Loading chart data...
ConvaTec Group Plc (CNVVF) Overview
ConvaTec Group Plc (CNVVF) is a publicly traded company in the Healthcare sector , specifically within the Medical - Instruments & Supplies industry . As of the latest trading session, CNVVF trades at $2.67 with a market capitalization of 5.20B . Over the past 52 weeks, CNVVF has traded between $2.30 and $3.95 , with the current price positioned at approximately 22% of this range . The stock cu...
Key Takeaways
- Operates in the Healthcare sector (Medical - Instruments & Supplies)
- Market cap: 5.20B
- Current price: $2.67
- 52-week range: $2.30 - $3.95
- P/E ratio: 29.67
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
ConvaTec Group Plc is a global medical technology company focused on creating, producing, and distributing a wide array of healthcare products. Their offerings span several key areas: Advanced Wound Management: This includes specialized dressings and...
Company Information
- CEO
- Jonathan Peter Mason
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Employees
- 10489
Contact Information
- Address
- 3 Forbury Place
- Country
- GB
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 29.7)
✓ Lower volatility stock (Beta: 0.76) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for ConvaTec Group Plc shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for ConvaTec Group Plc
- ⚠Investors should consider how ConvaTec Group Plc fits within their overall portfolio allocation
Market Cap
5.20B
P/E Ratio (TTM)
29.67
Beta
0.76
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare CNVVF with peer companies:
- Price
- $84.10
- Market cap
- 4.46B
- Price
- $50.75
- Market cap
- 4.26B
- Price
- $9.94
- Market cap
- 4.17B
- Price
- $20.00
- Market cap
- 5.45B
- Price
- $3.49
- Market cap
- 6.10B
- Price
- $7.60
- Market cap
- 5.64B
- Price
- $12.00
- Market cap
- 5.93B
- Price
- $14.07
- Market cap
- 6.95B
- Price
- $9.03
- Market cap
- 5.61B
- Price
- $354.92
- Market cap
- 4.67B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.